中国循证医学杂志

中国循证医学杂志

血浆纤维蛋白表达水平与肾细胞癌风险相关性的 Meta 分析

查看全文

目的 系统评价血浆纤维蛋白原表达水平与肾细胞癌患者临床病理特点及预后的相关性。 方法 计算机检索 PubMed、EMbase、The Cochrane Library(2016 年 5 期)、CNKI、CBM 和 WanFang Data 数据库,搜集血浆纤维蛋白原表达水平与肾癌风险相关性的队列研究,检索时限均为建库至 2016 年 5 月。由 2 名研究员独立筛选文献、提取资料并评价纳入研究的偏倚风险后,使用 RevMan 5.3 软件对数据进行 Meta 分析。 结果 共纳入 7 个队列研究,共 3 744 例患者。Meta 分析结果显示:血浆纤维蛋白原低表达组的肾细胞癌患者在总生存率[HR=2.13,95%CI(1.74,2.61),P<0.000 01]、肿瘤特异性生存率[HR=3.12,95%CI(2.19,4.44),P<0.000 01]方面均显著高于高表达组。亚组分析结果显示,血浆纤维蛋白原的表达水平在 TNM 临床分期Ⅲ~Ⅳ期明显高于Ⅰ~Ⅱ期[OR=0.27,95%CI(0.13,0.55),P=0.000 3],在 Fuhrman 病理分级 G3+G4 期明显高于 G1+G2 期[OR=0.49,95%CI(0.40,0.59),P<0.000 01],且差异均有统计学意义;但表达水平在性别上无差异[OR=0.85,95%CI(0.69,1.05),P=0.14]。 结论 现有证据表明,血浆纤维蛋白原的表达水平与肾细胞癌患者临床病理和预后具有明显相关性。受纳入研究数量和质量的限制,以上结论仍需进一步开展更多高质量的研究加以验证。

Objective To systematically review the prognostic and clinicopathological value of plasma fibrinogen in renal cell carcinoma (RCC). Methods An electronic search of the PubMed, EMbase, The Cochrane Library (Issue 5, 2016), CNKI, CBM and WanFang Data databases was performed to collect cohort studies about the prognostic value of plasma fibrinogen in RCC from inception to May 2016. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then meta-analysis was performed by using RevMan 5.3 software. Results A total of 3 744 RCC patients from 7 cohort studies were included. The results of meta-analysis showed that the lower plasma fibrinogen expression group was superior to the higher expression group in overall survival (HR=2.13, 95%CI 1.74 to 2.61,P<0.00 001) and cancer-specific survival (HR=3.12, 95%CI 2.19 to 4.44,P<0.00 001). Subgroup analysis showed that plasma fibrinogen expression was higher in stage Ⅲ to Ⅳ than stage ⅠtoⅡ (OR=0.27, 95%CI 0.13 to 0.55,P=0.000 3) and was higher in Fuhrman grading G3+G4 than grading G1+G2 (OR=0.49, 95%CI 0.40 to 0.59,P<0.000 01). However, the level of plasma fibrinogen was not found to be associated with gender (OR=0.85, 95%CI 0.69 to 1.05,P=0.14). Conclusion Current evidence shows plasma fibrinogen expression is associated with the prognostic and clinicopathological value of RCC. Due to limited quantity and quality of included studies, the above conclusions are still needed to be verified by more high quality studies.

关键词: 血浆纤维蛋白原; 肾细胞癌; Meta 分析; 队列研究

Key words: Plasma fibrinogen; Renal cell carcinoma; Meta-analysis; Cohort study

引用本文: 胥芸芸, 翟振兴, 李桂香. 血浆纤维蛋白表达水平与肾细胞癌风险相关性的 Meta 分析. 中国循证医学杂志, 2017, 17(5): 529-535. doi: 10.7507/1672-2531.201606076 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
2. 田跃军, 郭琦, 陈朝晖, 等. 缺氧诱导因子-1α 蛋白表达与肾细胞癌风险相关性的 Meta 分析. 中国循证医学杂志, 2015, 15(9): 1035-1041.
3. Custodio S, Joaquim A, Peixoto V, et al. Metastatic renal cell carcinoma: the importance of immunohistochemistry in differential diagnosis. Case Rep Oncol, 2012, 5(1): 30-34.
4. Eisengart LJ, MacVicar GR, Yang XJ. Predictors of response to targeted therapy in renal cell carcinoma. Arch Pathol Lab Med, 2012, 136(5): 490-495.
5. Palumbo JS, Degen JL. Mechanisms coupling the hemostatic system to colitis-associated cancer. Thromb Res, 2010, 125(Suppl 2): S39-43.
6. Mei Y, Zhao S, Lu X, et al. Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer. PLoS One, 2016, 11(1): e0146233.
7. Troppan KT, Melchardt T, Wenzl K, et al. The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma. J Clin Pathol, 2016, 69(4): 326-330.
8. Zhu LR, Li J, Chen P, et al. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Clin Transl Oncol, 2016, 18(2): 178-188.
9. Zhang D, Zhou X, Bao W, et al. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma. Oncotarget, 2015, 6(35): 38410-38420.
10. Du J, Zheng JH, Chen XS, et al. High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma. Int J Clin Oncol, 2013, 18(3): 517-523.
11. Pichler M, Hutterer GC, Stojakovic T, et al. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer, 2013, 109(5): 1123-1129.
12. Erdem S, Amasyali AS, Aytac O, et al. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics. Urol Oncol, 2014, 32(7): 1031-1040.
13. Niedworok C, Dorrenhaus B, Vom Dorp F, et al. Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters. World J Urol, 2015, 33(10): 1541-1552.
14. Sasaki T, Onishi T. Pretherapeutic Plasma Fibrinogen Level is an Independent Survival Predictor in Renal Cell Carcinoma. Oncol Res Treat, 2015, 38(7-8): 374-378.
15. Obata J, Tanaka N, Mizuno R, et al. Plasma fibrinogen level: An independent prognostic factor for disease-free survival and cancer-specific survival in patients with localized renal cell carcinoma. BJU Int, 2016, 118(4):598-603
16. Lee H, Lee SE, Byun SS, et al. Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment. Medicine (Baltimore), 2016, 95(4): e2626.
17. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol, 2002, 3(1): 27-34.
18. Son HJ, Park JW, Chang HJ, et al. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol, 2013, 20(9): 2908-2913.
19. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci, 2001, 936: 406-425.
20. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood, 2000, 96(12): 3772-3778.
21. Sahni A, Simpson-Haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost, 2008, 6(1): 176-183.
22. Witsch E, Sela M, Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda), 2010, 25(2): 85-101.
23. Zheng S, Shen J, Jiao Y, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci, 2009, 100(5): 859-865.
24. Shu YJ, Weng H, Bao RF, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer, 2014, 566(14): 1-12.
25. Tsimafeyeu IV, Demidov LV, Madzhuga AV, et al. Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma. J Exp Clin Cancer Res, 2009, 30(28): 1-8.
26. 王燕, 赵玉玲, 曾红春, 等. 超声造影对肾脏良恶性肿瘤诊断价值的 Meta 分析. 中国循证医学杂志, 2014, 14(10): 1206-1209.